Cerenome, Inc. (CNSY) stock
CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.71+0.08 (+12.14%)
Close on Nov 18, 2026Market cap $5.36MP/E –Yield –
Cerenome price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cerenome's price to book ratio was 1.1× on Nov 11, 2026, against 15.9× a year earlier. Over the last 5 years it ranged from 0.1× to 83.5×, with a median of 0.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.1× | −12.3 |
| 2025 | Dec 31, 2025 | 13.3× | +9.9 |
| 2024 | Jan 31, 2024 | 3.5× | +0.4 |
| 2023 | Dec 29, 2023 | 3.0× | +3.0 |
| 2022 | Dec 30, 2022 | 0.1× | −0.0 |
| 2021 | Dec 31, 2021 | 0.1× | −0.2 |
| 2020 | Dec 31, 2020 | 0.2× | −2.6 |
| 2019 | Dec 31, 2019 | 2.8× | +2.8 |
| 2018 | Dec 31, 2018 | 0.0× | −0.1 |
| 2017 | Dec 29, 2017 | 0.1× | −0.1 |
| 2016 | Dec 30, 2016 | 0.2× | – |
See a number that looks wrong?